Cross Country Healthcare, Inc.

NasdaqGS:CCRN Stock Report

Market Cap: US$527.5m

Cross Country Healthcare Past Earnings Performance

Past criteria checks 2/6

Cross Country Healthcare has been growing earnings at an average annual rate of 52.9%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 26.5% per year. Cross Country Healthcare's return on equity is 9.8%, and it has net margins of 2.6%.

Key information

52.9%

Earnings growth rate

53.3%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate26.5%
Return on equity9.8%
Net Margin2.6%
Next Earnings Update31 Jul 2024

Recent past performance updates

Recent updates

Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet

Feb 22
Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet

Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Feb 09
Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital

Oct 09
Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital

Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?

Sep 13
Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?

These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well

Aug 19
These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Jun 26
Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?

Jun 08
At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?

Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

Apr 28
Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Mar 15
Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching

Mar 02
Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching

If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity

Jan 20
If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity

Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet

Jan 05
Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet

Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?

Oct 29
Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?

Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital

Oct 14
Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital

Paring My Cross Country Healthcare Gains

Sep 29

Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?

Sep 26
Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?

Cross Country Healthcare to acquire assets of Mint Medical Physician Staffing, LP and Lotus Medical Staffing LLC

Sep 14

Cross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet

Aug 21
Cross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet

Cross Country Healthcare rises postmarket on $100M stock buyback program

Aug 16

Cross Country Healthcare Q2 Non-GAAP EPS, revenue beats, Q3 guidance provided

Aug 03

Is Cross Country Healthcare, Inc. (NASDAQ:CCRN) Potentially Undervalued?

Jun 16
Is Cross Country Healthcare, Inc. (NASDAQ:CCRN) Potentially Undervalued?

Buying Back In To Cross Country Healthcare

May 17

Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

May 11
Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

Revenue & Expenses Breakdown

How Cross Country Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:CCRN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 241,776462900
31 Dec 232,020733150
30 Sep 232,2341023270
30 Jun 232,4281243370
31 Mar 232,6411563440
31 Dec 222,8071883350
30 Sep 222,8192273180
30 Jun 222,5582162910
31 Mar 222,1361752520
31 Dec 211,6771322200
30 Sep 211,252591970
30 Jun 211,071341850
31 Mar 2195691770
31 Dec 20836-131770
30 Sep 20836-191770
30 Jun 20851-211810
31 Mar 20837-581840
31 Dec 19822-581840
30 Sep 19808-761840
30 Jun 19800-741840
31 Mar 19801-201830
31 Dec 18816-171820
30 Sep 18835311830
30 Jun 18863381870
31 Mar 18868411880
31 Dec 17865381890
30 Sep 1786821890
30 Jun 1785491870
31 Mar 17845-131850
31 Dec 1683481800
30 Sep 16804101740
30 Jun 1678511680
31 Mar 16778211640
31 Dec 1576741620
30 Sep 15762-101640
30 Jun 15756-221650
31 Mar 15686-281530
31 Dec 14618-321420
30 Sep 14539-641270
30 Jun 14458-551120
31 Mar 14446-541100
31 Dec 13438-541070
30 Sep 13441-41070

Quality Earnings: CCRN has high quality earnings.

Growing Profit Margin: CCRN's current net profit margins (2.6%) are lower than last year (5.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CCRN has become profitable over the past 5 years, growing earnings by 52.9% per year.

Accelerating Growth: CCRN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CCRN had negative earnings growth (-70.6%) over the past year, making it difficult to compare to the Healthcare industry average (14.9%).


Return on Equity

High ROE: CCRN's Return on Equity (9.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.